Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRBP Corbus Pharmaceuticals

Market Closed 03-21 16:00:00 EDT

5.75

-0.25

-4.17%

盘后5.90

+0.15+2.61%

19:22 EDT

High5.93	Low5.65	Vol428.33K
Open5.91	D1 Closing6.00	Amplitude4.71%
Mkt Cap70.34M	Tradable Cap42.78M	Total Shares12.23M
T/O2.47M	T/O Rate5.76%	Tradable Shares7.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals","latestPrice":5.75,"timestamp":1742587200000,"preClose":6,"halted":0,"volume":428332,"hourTrading":{"tag":"盘后","latestPrice":5.9,"preClose":5.75,"latestTime":"19:22 EDT","volume":3027,"amount":17786.4258,"timestamp":1742599369228},"delay":0,"floatShares":7440646,"shares":12232228,"eps":-3.68369,"marketStatus":"Market Closed","change":-0.25,"latestTime":"03-21 16:00:00 EDT","open":5.91,"high":5.9325,"low":5.65,"amount":2474179.699916,"amplitude":0.047083,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.68369,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1742803200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":6,"preHourTrading":{"tag":"盘前","latestPrice":6,"preClose":6,"latestTime":"08:59 EDT","volume":324,"amount":1941.9683904,"timestamp":1742561996710},"postHourTrading":{"tag":"盘后","latestPrice":5.9,"preClose":5.75,"latestTime":"19:22 EDT","volume":3027,"amount":17786.4258,"timestamp":1742599369228},"volumeRatio":1.90415,"impliedVol":1.0517,"impliedVolPercentile":0.396},"requestUrl":"/m/hq/s/CRBP/tweets","defaultTab":"tweets","newsList":[{"id":"2521095252","title":"Corbus Pharmaceuticals Announces Board Member Departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2521095252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521095252?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 04:57","pubTimestamp":1742590671,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals ( ($CRBP) ) has shared an announcement. On March 20, 2025, Dr. Peter Salzmann informed Corbus Pharmaceuticals Holdings, Inc....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-announces-board-member-departure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-announces-board-member-departure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2521280254","title":"Corbus Pharmaceuticals Holdings Inc. Stock Sheds 4.2%, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2521280254","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521280254?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 04:34","pubTimestamp":1742589240,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. slid 4.2% to $5.75 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 17,784.05 and the Dow Jones Industrial Average rising 0.1% to 41,985.35.This was the stock's fourth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 90.7% below its 52-week high of $61.90, which the company achieved on July 31st.The stock underperformed when compared to some of its competitors, as Vanda Pharmaceuticals Inc. fell 3.0% to $4.77, Fortress Biotech Inc. rose 0.6% to $1.71, and Viking Therapeutics Inc. rose 2.12% to $28.95.Trading volume totaled 427,587, compared to the 50-day average of 243,226.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2520631164","title":"After Plunging -22.69% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520631164","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520631164?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 21:35","pubTimestamp":1742477703,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals  has been on a downward spiral lately with significant selling pressure. After declining 22.7% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.We use Relative Strength Index , one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.The heavy selling of CRBP shares appears to be in the process of exhau","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/plunging-22-69-4-weeks-133503651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RSI","BK4139","BK4150","CRBP"],"gpt_icon":0},{"id":"2520958408","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2520958408","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520958408?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 05:25","pubTimestamp":1742333100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 9.05% to $6.33 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.71% to 17,504.12 and Dow Jones Industrial Average  falling 0.62% to 41,581.31.The stock's fall snapped a two-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 89.77% short of its 52-week high of $61.90, which the company reached on July 31st.The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 1.77% to $4.99, Fortress Biotech Inc.  fell 1.71% to $1.72, and Viking Therapeutics Inc.  fell 1.24% to $29.46.Trading volume  eclipsed its 50-day average volume of 236,857.Data source: Dow Jones Market Data, FactSet. Data compiled March 18, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2520813616","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2520813616","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520813616?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 05:24","pubTimestamp":1742246640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 2.50% to $6.96 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.31% to 17,808.66 and the Dow Jones Industrial Average  rising 0.85% to 41,841.63.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 88.76% below its 52-week high of $61.90, which the company achieved on July 31st.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 2.01% to $5.08, Fortress Biotech Inc.  rose 4.79% to $1.75, and Viking Therapeutics Inc.  fell 3.43% to $29.83.Trading volume  remained 132,170 below its 50-day average volume of 236,856.Data source: Dow Jones Market Data, FactSet. Data compiled March 17, 2025.This content was created by MarketWatch, which is opera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2519337640","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.8%, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2519337640","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519337640?lang=en_us&edition=full_marsco","pubTime":"2025-03-15 04:34","pubTimestamp":1741984440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. rose 5.8% to $6.79 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.6% to 17,754.09 and the Dow Jones Industrial Average rising 1.7% to 41,488.19.Corbus Pharmaceuticals Holdings Inc. closed 89.0% short of its 52-week high of $61.90, which the company achieved on July 31st.The stock outperformed some of its competitors, as Vanda Pharmaceuticals Inc. rose 1.2% to $4.98, Fortress Biotech Inc. rose 3.1% to $1.67, and Viking Therapeutics Inc. rose 3.90% to $30.89.Trading volume totaled 135,971, compared to the 50-day average of 244,556.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2519861185","title":"Corbus Pharmaceuticals Holdings Inc. Stock Sheds 7.1%, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2519861185","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519861185?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 04:33","pubTimestamp":1741897980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.1% to $6.42 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.0% to 17,303.01 and Dow Jones Industrial Average falling 1.3% to 40,813.57.The stock's fall snapped a two-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 89.6% short of its 52-week high of $61.90, which the company achieved on July 31st.The stock underperformed when compared to some of its competitors, as Vanda Pharmaceuticals Inc. fell 0.6% to $4.92, Fortress Biotech Inc. fell 6.4% to $1.62, and Viking Therapeutics Inc. rose 0.61% to $29.73.Trading volume totaled 122,921, compared to the 50-day average of 247,155.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2518077011","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2518077011","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518077011?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 05:24","pubTimestamp":1741728240,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 1.33% to $6.88 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.18% to 17,436.10 and Dow Jones Industrial Average  falling 1.14% to 41,433.48.Corbus Pharmaceuticals Holdings Inc. closed 88.89% short of its 52-week high of $61.90, which the company reached on July 31st.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  rose 5.73% to $4.98, Fortress Biotech Inc.  fell 0.57% to $1.73, and Viking Therapeutics Inc.  fell 5.15% to $26.52.Trading volume  remained 7,175 below its 50-day average volume of 248,544.Data source: Dow Jones Market Data, FactSet. Data compiled March 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independe","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2518776647","title":"Corbus Pharmaceuticals Is Maintained at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2518776647","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518776647?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 03:23","pubTimestamp":1741720980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2025 15:23 ET (19:23 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2518732677","title":"Corbus Pharmaceuticals (CRBP) Gets a Buy from William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2518732677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518732677?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 02:25","pubTimestamp":1741717521,"startTime":"0","endTime":"0","summary":"William Blair analyst Andy Hsieh reiterated a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) today. The company’s shares opened toda...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/corbus-pharmaceuticals-crbp-gets-a-buy-from-william-blair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/corbus-pharmaceuticals-crbp-gets-a-buy-from-william-blair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2518093746","title":"Corbus Pharmaceuticals: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2518093746","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518093746?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 20:17","pubTimestamp":1741695422,"startTime":"0","endTime":"0","summary":"NORWOOD, Mass.  — NORWOOD, Mass.  — Corbus Pharmaceuticals Holdings Inc.  on Tuesday reported a loss of $9.5 million in its fourth quarter.The Norwood, Massachusetts-based company said it had a loss of 78 cents per share.The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.30 per share.For the year, the company reported a loss of $40.2 million, or $3.68 per share.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corbus-pharmaceuticals-q4-earnings-snapshot-121702305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRBP"],"gpt_icon":0},{"id":"2518753748","title":"Corbus Pharmaceuticals Q4 EPS $(0.78) Beats $(1.20) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518753748","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518753748?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 20:09","pubTimestamp":1741694987,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Q4 EPS $(0.78) Beats $(1.20) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44244330/corbus-pharmaceuticals-q4-eps-0-78-beats-1-20-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Corbus Pharmaceuticals Q4 EPS $(0.78) Beats $(1.20) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2518748428","title":"Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748428","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518748428?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 20:00","pubTimestamp":1741694400,"startTime":"0","endTime":"0","summary":"CRB-701 Nectin-4 targeting ADC demonstrates encouraging results in Phase 1 Western study Fast Track Designation granted by FDA for CRB-701 to treat metastatic cervical cancerCRB 913 SAD/MAD obesity st","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040487/0/en/Corbus-Pharmaceuticals-Reports-Q4-and-2024-Financial-Results-and-Provides-a-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4080","CRBP","BK4139","ADC"],"gpt_icon":0},{"id":"2517546177","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2517546177","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517546177?lang=en_us&edition=full_marsco","pubTime":"2025-03-08 06:24","pubTimestamp":1741386240,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 2.58% to $6.79 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.70% to 18,196.22 and the Dow Jones Industrial Average  rising 0.52% to 42,801.72.The stock's fall snapped a two-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 89.03% below its 52-week high of $61.90, which the company reached on July 31st.The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc.  fell 1.22% to $4.85, Fortress Biotech Inc.  rose 1.32% to $1.54, and Viking Therapeutics Inc.  rose 1.46% to $29.10.Trading volume  remained 79,359 below its 50-day average volume of 247,514.Data source: Dow Jones Market Data, FactSet. Data compiled March 7, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. M","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2517158621","title":"Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517158621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517158621?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 19:00","pubTimestamp":1741258816,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ARS Pharmaceuticals (SPRY – Research Report) and Cor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ars-pharmaceuticals-spry-and-corbus-pharmaceuticals-crbp?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ars-pharmaceuticals-spry-and-corbus-pharmaceuticals-crbp?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","SPRY","BK4139","BK4137","HCSG"],"gpt_icon":0},{"id":"2517398920","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517398920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517398920?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 06:25","pubTimestamp":1741213500,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 1.03% to $6.84 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 1.46% to 18,552.73 and the Dow Jones Industrial Average  rising 1.14% to 43,006.59.The stock's rise snapped a two-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 88.95% below its 52-week high of $61.90, which the company achieved on July 31st.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  rose 6.65% to $5.13, Fortress Biotech Inc.  rose 1.96% to $1.56, and Viking Therapeutics Inc.  fell 0.53% to $27.94.Data source: Dow Jones Market Data, FactSet. Data compiled March 5, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2517821519","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2517821519","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517821519?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 06:23","pubTimestamp":1741126980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 2.73% to $6.77 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.35% to 18,285.16 and Dow Jones Industrial Average  falling 1.55% to 42,520.99.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 89.06% below its 52-week high of $61.90, which the company reached on July 31st.The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  rose 1.91% to $4.81, Fortress Biotech Inc.  rose 0.66% to $1.53, and Viking Therapeutics Inc.  rose 9.30% to $28.09.Trading volume  remained 89,475 below its 50-day average volume of 267,573.Data source: Dow Jones Market Data, FactSet. Data compiled March 4, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2516466605","title":"Corbus Pharmaceuticals Holdings Inc. Stock Slides 7.8%, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2516466605","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516466605?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 05:33","pubTimestamp":1741037580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.8% to $6.96 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.6% to 18,350.19 and Dow Jones Industrial Average falling 1.5% to 43,191.24.Corbus Pharmaceuticals Holdings Inc. closed 88.8% short of its 52-week high of $61.90, which the company reached on July 31st.The stock demonstrated a mixed performance when compared to some of its competitors, as Vanda Pharmaceuticals Inc. fell 0.8% to $4.72, Fortress Biotech Inc. fell 3.2% to $1.52, and Viking Therapeutics Inc. fell 10.98% to $25.70.Trading volume totaled 241,567, compared to the 50-day average of 272,326.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2514843329","title":"William Blair Initiates Corbus Pharmaceuticals at Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2514843329","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514843329?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 20:56","pubTimestamp":1740747378,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals (CRBP) has an average rating of buy and mean price target of $56.78, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRBP"],"gpt_icon":0},{"id":"2514326990","title":"Corbus Pharmaceuticals Initiated at Outperform by William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326990","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326990?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 20:33","pubTimestamp":1740745980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 28, 2025 07:33 ET (12:33 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":-0.1532},{"period":"1month","weight":-0.2628},{"period":"3month","weight":-0.5577},{"period":"6month","weight":-0.7053},{"period":"1year","weight":-0.8493},{"period":"ytd","weight":-0.5127}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":-0.0799},{"period":"3month","weight":-0.046},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.08},{"period":"ytd","weight":-0.0377}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.398096},{"month":2,"riseRate":0.3,"avgChangeRate":-0.057173},{"month":3,"riseRate":0.6,"avgChangeRate":0.214052},{"month":4,"riseRate":0.444444,"avgChangeRate":0.005809},{"month":5,"riseRate":0.7,"avgChangeRate":0.087774},{"month":6,"riseRate":0.3,"avgChangeRate":-0.064872},{"month":7,"riseRate":0.2,"avgChangeRate":-0.089768},{"month":8,"riseRate":0.6,"avgChangeRate":0.104161},{"month":9,"riseRate":0.2,"avgChangeRate":-0.130103},{"month":10,"riseRate":0.2,"avgChangeRate":-0.132775},{"month":11,"riseRate":0.8,"avgChangeRate":0.148081},{"month":12,"riseRate":0.3,"avgChangeRate":-0.116028}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Corbus Pharmaceuticals,CRBP,Corbus Pharmaceuticals股票,Corbus Pharmaceuticals股票老虎,Corbus Pharmaceuticals股票老虎国际,Corbus Pharmaceuticals行情,Corbus Pharmaceuticals股票行情,Corbus Pharmaceuticals股价,Corbus Pharmaceuticals股市,Corbus Pharmaceuticals股票价格,Corbus Pharmaceuticals股票交易,Corbus Pharmaceuticals股票购买,Corbus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}